Back to Search Start Over

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

Authors :
Hodgson DC
Gilbert ES
Dores GM
Schonfeld SJ
Lynch CF
Storm H
Hall P
Langmark F
Pukkala E
Andersson M
Kaijser M
Joensuu H
Fosså SD
Travis LB
Source :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2007 Apr 20; Vol. 25 (12), pp. 1489-97. Date of Electronic Publication: 2007 Mar 19.
Publication Year :
2007

Abstract

Purpose: Hodgkin's lymphoma (HL) survivors are known to be at substantially increased risk of solid cancers (SC). However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis.<br />Patients and Methods: We identified 18,862 5-year HL survivors from 13 population-based cancer registries in North America and Europe. Poisson regression was used to evaluate the effects of age at diagnosis, attained age, latency, sex, treatment, and year of diagnosis on the RR and EAR of SC.<br />Results: Among 1,490 identified SC, 850 were estimated to be in excess. For most cancer sites, both RR and EAR decreased with age at HL diagnosis and showed strong dependencies on attained age. For a patient diagnosed at age 30 years and survived to > or = 40 years, modeled risks were significantly elevated for cancers of the breast (RR = 6.1), other supradiaphragmatic sites (RR = 6.0), and infradiaphragmatic sites (RR = 3.7); the largest RR (20-fold) was observed for malignant mesothelioma. Thirty-year cumulative risks of SC for men and women diagnosed at 30 years were 18% and 26%, respectively, compared with 7% and 9%, respectively, in the general population. For young HL patients, risks of breast and colorectal cancers were elevated 10 to 25 years before the age when routine screening would be recommended in the general population.<br />Conclusion: Multivariable modeling demonstrates for the first time temporal changes in SC risk not evident in unadjusted analyses, and can facilitate the development of individualized risk assessment and the creation of screening strategies for early detection.

Details

Language :
English
ISSN :
1527-7755
Volume :
25
Issue :
12
Database :
MEDLINE
Journal :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
17372278
Full Text :
https://doi.org/10.1200/JCO.2006.09.0936